Our publication on quality of life in patients with autoimmune hepatitis is now online! Many thanks to all co-authors! Thanks to your dedication and the numerous inclusions, we were able to achieve this result!
@Tom__gevers@AASLDtweets
Check out the article:
Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Full VANISH2 trial results and Research Summary: https://t.co/yDFhCI9KNA
Romée Snijders 🇳🇱 top 50 physician!
👔Which physician has the greatest significance for 🇳🇱Dutch healthcare?
@romeesnijders made it to the 🔝 5⃣0⃣
➡️connector, achiever, & maximizer par excellence
👍Well done Romée!
@Tom__gevers@ERN_RARE_LIVER
https://t.co/et8AgClYSv
💥MASLD emerging from the fog of #fattyliver💥
➡️New nomenclature aims to boost awareness of #MASLD beyond the focus on obesity❗️
👇Find out more👇
Editorial➡️https://t.co/7Jw41R0wCe
Delphi consensus statement on #NewNomenclature➡️https://t.co/PlTfC3YuFC
#LiverTwitter